The reduction of ovarian cancer (OC) risk in women with a history of tubal ligation (TL) has been reported repeatedly, mostly on small populations. We have aimed to provide a critical overview of the studies available to date and to conduct a meta-analysis.
Introduction
In the 1970s, the theory of growing incidence of ovarian cancer (OC) as a result of increased exposure of ovaries to carcinogens that are transported to the peritoneal cavity through the fallopian tubes was first suggested (Woodruff, 1979) . The protective effect of tubal ligation (TL) was later demonstrated in several case -control studies in 1980s (Mori et al.,1984 (Mori et al., , 1988 Hartge et al., 1988; Whittemore et al., 1988; Shu et al., 1989) . There have been several case-control studies published to date, as well as five prospective cohort studies, which mostly had consistent outcomes showing a reduced risk of OC in women after TL, although the odds ratios varied substantially. The risk reduction was significant, comparable or even superior to that achieved by oral contraceptives (Risch et al., 1996; Tworoger et al., 2007) . Unlike oral contraceptives, the protective influence of TL has received little attention particularly due to the elusive underlying mechanism. There were a number of theories debated, in particular, the prevention of carcinogenic talc transportation from the vagina and external genitalia into the peritoneal cavity, yet it was highly unlikely that any of those theories would explain the significant risk reduction. Over the past few years, however, there have been a growing number of arguments supporting the potential origin of ovarian epithelial tumors from tissues that are embryologically derived from the Müllerian ducts, including endometrial cells, which are transported from the endometrial cavity by retrograde menstruation (Dubeau, 2008) .
The aim of this review was to summarize available studies, collating data on the OC risk in women who underwent TL and perform meta-analysis on the OC risk in such population and in subgroups according to age, time interval since the TL, histological types of OC and BRCA mutation.
Methods

Identification of studies
Papers were identified from review and original articles, using Medline and PubMed, up to September 2009. References from relevant articles were searched for additional relevant studies. A total of 32 casecontrol (Mori et al., 1984 (Mori et al., , 1988 Harlow et al., 1988; Hartge et al., 1988; Whittemore et al., 1988 Whittemore et al., , 1992a Booth et al., 1989; Shu et al., 1989; Irwin et al., 1991; Chen et al., 1992; Risch et al., 1994; Rosenberg et al., 1994; Cramer and Xu, 1995; Purdie et al., 1995; Risch et al., 1996; Rosenblatt and Thomas, 1996; Cornelison et al., 1997; Green et al., 1997; Modugno et al., 2001 Modugno et al., , 2004 Narod et al., 2001; Ness et al., 2001; Tung et al., 2003; McGuire et al., 2004; Mills et al., 2004; Pike et al., 2004; McLaughlin et al., 2007; Jordan et al., 2008; Moorman et al., 2008; Nagle et al., 2008) , 5 prospective cohort (Hankinson et al., 1993; Miracle-McMahill et al., 1997; Tworoger et al., 2007; Antoniou et al., 2009; Dorjgochoo et al., 2009) and 3 historical cohort (Koch et al., 1984; Kreiger et al., 1997; Kjaer et al., 2004) studies were identified and included in the overview (Tables 1-3) .
The studies available were categorized into three groups for the main meta-analysis (Tables 1-3) . 'Excluded' were those studies not reporting any estimate of OC after TL, those with a substantially overlapping study population, those performed in high-risk population and finally those having only specific histological types of OC as an outcome. For a strict selection analysis, well-designed case-control studies having epithelial OC as an outcome were included. All other studies not excluded from the main analysis, including historical cohort ones, formed a group for an 'extended selection analysis'. Several studies not selected for the main meta-analysis were included in the subgroups, which evaluated secondary end-points, as they provided further stratification of results (Tables 1-3) . Overview of used end-points is summarized in Table 4 .
Data analysis
Precision of effect size estimates in individual studies was assessed on the basis of confidence intervals or P-values. Standard error of the log relative risk estimate is given by:
where RR and RR are upper and lower limit of given 95% confidence interval, or
where Z P is the value of standardized normal test statistic corresponding to the given P-value. Rare-disease assumption was verified for OC in normal-risk population and, therefore, we treated both odds ratios and rate ratios as estimates of relative risk (Greenland, 1987) . Fixed-effect inversevariance method was used for pooling results of primary studies.
Heterogeneity within given trial set was assessed using x 2 distributed Cochran's Q statistic (null hypothesis is zero heterogeneity) computed as the sum of weighted square differences of individual study estimates and pooled estimate of the effect size. Measured I 2 is used for quantifying the percentage of total variation across the studies attributable to heterogeneity rather than a chance (Higgins et al., 2003) . Subgroup analysis was performed separately for groups by years from TL, cell type of OC and its behavior, age at TL and the presence of BRCA mutation. These results were presented by standard summary statistics according to data availability (Table 4) . In these stratified analyses, both between-group and within-group heterogeneity were tested. Between-group heterogeneity was tested using x 2 statistics. Observed heterogeneity within subgroups was always reported along with the results of statistical tests, as the resulting P-value for test of homogeneity between subgroups might be understated in such cases (Harris et al., 2008) . All calculations were performed using metan command (Harris et al., 2008) in Stata 10.1 software (StataCorp, 2007) .
Results
Risk in population
Following the exclusion of 16 case -cohort and 3 prospective cohort studies due to reasons listed previously and summarized in Tables 1-3, the risk of OC in relation to TL was analyzed in 16 case-control, 3 retrospective cohort and 2 prospective cohort studies.
Of the 13 strictly selected studies, 7 of them found that TL significantly reduced the risk of OC. The other six studies did not find significant evidence of a difference; however, in five of these six studies, the direction of the effect was in favor of TL. Meta-analysis of the above 13 studies confirmed that TL reduces the risk of epithelial OC by 34% (RR ¼ 0.66, 95% CI 0.60 -0.73) (Fig. 1) (21 studies), noticeable increase in heterogeneity was observed (I 2 ¼ 38.3%, P ¼ 0.039).
Age and time dependency of risk modulation
The analysis of the age when TL was performed and relative risk dependency on interval since the procedure are of great importance when discussing the potential bias affecting the assessment of OC risk. The presence of reduced risk only shortly after TL would suggest screening bias, i.e. the removal of impaired ovaries in the course of the procedure. A positive effect on the risk of OC in older women only would indirectly support the presence of selection bias, i.e. performing TL in women with higher parity and longer history of using oral contraceptives. The results of the subanalysis on age at TL appear to be intrinsically heterogeneous and inconclusive. Some studies proved an increasing protective effect of TL with increasing age at TL (Rosenblatt and Thomas, 1996; Dorjgochoo et al., 2009) , whereas others contradicted this observation (Cornelison et al., 1997; Kreiger et al., 1997) . However, graphical display of data available on the relationship between age at TL and relative risk of OC did not show any apparent or significant trend (Fig. 2) .
Estimates of relative risk in 5-year categories since TL were not mutually different with confidence intervals overlapping with each other (Fig. 3) . The statistical significance of reduced RR was proved for the subgroup with the interval of 10-14 years since TL. Moreover, x 2 test did not confirm increased heterogeneity between time-related subgroups (P ¼ 0.590). Considering those results, we can conclude that the significant protective effect of TL against OC does not diminish in time, at least up to 14 years since the procedure.
Histological types of ovarian cancer
Evidence of a significant difference in risk-reducing effect of TL on different cell types of OC could greatly contribute to researching the mechanisms that play a role in ovarian carcinogenesis, in particular, when comparing the mucinous and non-mucinous epithelial cancers. A large-scale meta-analysis of 45 studies in 2008 showed a much more significant protective effect of oral contraceptive use on nonmucinous epithelial OCs, and there were several epidemiological studies demonstrating different risk parameters for mucinous epithelial histological types in comparison to serous or endometrioid types (Risch et al., 1996; Tung et al., 2003; Soegaard et al., 2007) . Only a limited number of studies listed above provided a subanalysis of individual histological types, and the results are further limited by the small size of patient populations. These results have, despite limitations, made it possible to conduct a meta-analysis. A significant decrease in risk for OC after TL was observed for invasive OCs (RR ¼ 0.68, 95% CI 0.61 -0.75), whereas the effect in borderline tumors was less apparent (RR ¼ 0.86, 95% CI 0.67 -1.10), with much wider confidence interval due to smaller group of cases (Fig. 4) . Significantly higher risk reduction was found for endometrioid invasive cancers (RR ¼ 0.40, 95% CI 0.30-0.53) in comparison with the other types. Less apparent but still significant reduction was shown for serous-invasive cancers (RR ¼ 0.73, 95% CI 0.63 -0.85), whereas it did not reach statistical significance for mucinous-invasive cancers (P ¼ 0.653) (Fig. 5) . There is statistically significant heterogeneity within the group of mucinous cancers (I 2 ¼ 72.8%, P ¼ 0.012).
Similar but statistically not significant reductions of risk were observed for serous (RR ¼ 0.87, 95% CI 0.57-1.31) and mucinous (RR ¼ 0.82, 95% CI 0.54 -1.27) borderline tumors.
BRCA mutation carriers
The potential risk-reducing effect of TL is of great importance especially for those groups in the population that carry an elevated hereditary risk of OC. Although the lifetime risk of developing OC Figure 2 Relative risk of ovarian cancer after tubal ligation: relationship between age at tubal ligation (exact numerical values assigned from presented intervals) and size of effect. Size of circles represents relative precision of effect estimates (inverse-variance estimate).
Ovarian cancer risk after tubal ligation is 1.8% in general population, it increases to 50-60% in BRCA1 and 25% in BRCA2 mutation carriers. Prophylactic adnexectomy proved to be the only method currently available, providing substantial risk reduction of both OC and breast cancers in BRCA mutation carriers (Kauff et al., 2002; Rebbeck et al., 2002) . The possibilities for young women still planning conception or those refusing the prophylactic procedure are rather limited. The data available document a significant reduction of OC risk in long-term users of oral contraceptives for BRCA1 mutation carriers McLaughlin et al., 2007) . Until now, there have been only three case-control and one prospective cohort study assessing the risk of OC in BRCA mutation carriers in relation to TL (McGuire et al., 2004; McLaughlin et al., 2007; Antoniou et al., 2009, Table 5) . Although there was a positive trend in all these studies, the differences were largely insignificant mostly due to small sample sizes; those were reflected by wide confidence intervals. The largest recent study so far analyzed groups of 2281 BRCA1 carriers and 1038 BRCA2 carriers from the International BRCA1/2 Carrier Cohort Study, carried out in Europe and Canada (Antoniou et al., 2009) . A weighted cohort approach was used to correct for biases caused by the selection of carriers from families with multiple diseases history and higher probability for genetic testing in younger age groups. Together, 400 unaffected women and 23 OC cases underwent TL, and the relative risk was significantly decreased for the whole group (RR ¼ 0.43, 95% CI 0.24 -0.75), and for BRCA1 carriers (RR ¼ 0.42, 95% Modugno et al., CI 0.22 -0.8), but this was not proved for BRCA2 carriers due to the limited number of cases. The ensuing risk reduction was comparable to the effect of oral contraceptive use.
Similar insignificant reductions of risk were observed for both BRCA1 and BRCA2 carriers in meta-analysis (Fig. 6) . The precision of effect size estimation was higher in BRCA1 carriers and reached statistical significance. Effect sizes are reported as odds ratios, because rare-disease assumption is questionable within high-risk population. Prospective study reporting HR (Antoniou et al., 2009) was, therefore, excluded from this analysis.
Even though the results available to date are not sufficient for drawing an unequivocal conclusion for BRCA mutation carriers, the results of the largest Antoniou study as well as the positive trend in other publications support the presence of protective effect of TL even in this group with hereditary increased risk of OC. 
Discussion
This systematic review and meta-analysis of studies available documented a significant reduction of OC risk in women who had undergone TL (Table 6 ). The significant protective effect was shown even in a subgroup of women after 10 -14 years since TL. The risk reduction was most profound in endometrioid cancers, smaller yet still present in serous cancers but unconfirmed for the mucinous tumors. A positive trend was observed also for borderline tumors and in the high-risk group of BRCA mutations carriers, but small size of the groups and less consistent outcomes did not make it possible to draw unequivocal conclusions.
The consistency of data available on risk reduction following TL was supported by the negligible heterogeneity in our meta-analysis of strictly selected studies. There were only two studies that found an insignificantly increased relative risk of OC in women after TL. The first of those was a retrospective historical cohort study, strongly limited by the small number of only four cases of OC with TL. Moreover, the results were only compared with the expected number of cancers obtained from another retrospective study (Koch et al., 1984) . The second being a large prospective cohort study from China, which followed more than 60 000 women for a medium follow-up of 7.5 years and did not find any preventive effect in relation to TL (Dorjgochoo et al., 2009) . Only 94 cases of OC were identified with the median follow-up of 7.5 years and only 19 of them had TL.
It should be emphasized that it will never be possible to carry out a prospective randomized trial evaluating the effect of TL on OC risk, and the evidence will always come from retrospective or observational studies. This paper has reviewed all the studies available, which were designed to address or at least contain data on the risk of OC in patients after TL. The main limitation of most studies proved to be the small patient populations, especially small number of cases of OC having undergone TL.
Two potential biases should be discussed, which may influence the assessment of TL effect on OC risk. Screening bias may result from the selective removal of suspicious ovaries during the TL (Harlow et al., 1988; Whittemore et al., 1988; Irwin et al., 1991) . Should this effect be significant, this would imply that the protective effect diminishes with time since the procedure. A majority of publications failed to confirm such vanishing trend (Shu et al., 1989; Rosenblatt and Thomas, 1996; Cornelison et al., 1997; Green et al., 1997; Kreiger et al., 1997; Miracle-McMahill et al., 1997; Kjaer et al., 2004) . Moreover, some studies aimed at eliminating the screening bias and excluded cancers diagnosed during or soon after the procedure (Irwin et al., 1991; Kreiger et al., 1997; Miracle-McMahill et al., 1997) and still confirmed a significantly reduced relative risk of Ovarian cancer risk after tubal ligation OC. Similarly, in our meta-analysis, a significantly reduced relative risk of OC was confirmed even in the subgroup 10 -14 years after the procedure. From the above arguments, it would appear that the screening bias cannot explain the significant risk reduction observed after the TL. Besides screening effect, the outcomes may be influenced also by selection bias, i.e. greater frequency of TL in women with more protective mechanisms in their history, i.e. higher parity or long-term use of oral contraceptives. Most studies have taken these aspects into consideration and adjusted the relative risk for parity and oral contraceptive use. Moreover, there was little heterogeneity observed in our meta-analysis, particularly with respect to the selected patient group, and thus a significant influence of interferences such as selection bias is very unlikely.
The protective effect of TL has, thus far, received little attention due to the inability to provide plausible explanation for the underlying mechanism. One plausible explanation of the TL effect is a mechanical barrier preventing retrograde transport of cancerogenic substances from the vagina and perineum. A potential effect of talc, as well as infectious agent, on ovarian cancerogenesis has been discussed (Longo and Young, 1979; Chen et al., 1992; Harlow et al., 1992; Wahlberg, 1994) . Available data are not fully consistent, and many studies failed to confirm any significant effect of talcum powder (Whittemore et al., 1988; Hankinson et al., 1993; Nagle et al., 2008) . It is unlikely that the sole effect of talc use could fully explain OC risk reduction after TL.
A new and attractive mechanism seems to be the prevention of the ascent of endometrial epithelial cells, which could be the source of significant proportion of epithelial ovarian and peritoneal cancers. The evidence is accumulating that OC could arise from tissues that are embryologically derived from the Mullerian ducts, i.e. the fallopian Statistically significant heterogeneity was observed within one of subgroups. *RR for endometrioid tumors is significantly lower (P , 0.001) than RR for serous and mucinous tumors.
tube, the secondary Müllerian system and endometrial cells (Dubeau, 2008) . Such mechanism would also provide a plausible explanation for the most profound risk reduction observed in our meta-analysis for endometrioid and serous types of cancer, which may originate from the endometrial epithelium.
In conclusion, this review summarized conclusive data on OC risk reduction after TL. Decreased risk, by 34%, was confirmed in meta-analysis. Protective effect is long-lasting, being significant in a subgroup with the interval of 10-14 years since the procedure. Our results should give an impulse for further research of the etiology of epithelial OCs as well as the importance of ascending transport of cells, possibly also other substances, originating from the uterine cavity. Furthermore, confirming the significant protection of BRCA carriers would make it possible to use TL in women who cannot undergo or do not accept prophylactic bilateral salpingo-oophorectomy.
